Serotonin Agents

"Serotonin Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.

Descriptor ID

D018490

MeSH Number(s)

D27.505.519.625.850

D27.505.696.577.850

Concept/Terms

Serotonin Agents

Serotonin Effect

Below are MeSH descriptors whose meaning is more general than "Serotonin Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Serotonin Agents [D27.505.519.625.850]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Serotonin Agents [D27.505.696.577.850]

Below are MeSH descriptors whose meaning is related to "Serotonin Agents".

Below are MeSH descriptors whose meaning is more specific than "Serotonin Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Serotonin Agents" by people in Harvard Catalyst Profiles by year, and whether "Serotonin Agents" was a major or minor topic of these publication.

Bar chart showing 26 publications over 19 distinct years, with a maximum of 3 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1997	2	0	2
1998	0	1	1
2000	1	0	1
2001	1	1	2
2002	1	1	2
2003	0	1	1
2004	0	1	1
2005	1	0	1
2006	1	2	3
2009	0	1	1
2010	1	0	1
2011	1	0	1
2013	0	1	1
2014	1	1	2
2015	0	1	1
2016	1	1	2
2018	1	0	1
2021	1	0	1

Below are the most recent publications written about "Serotonin Agents" by people in Profiles.

Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania. J Psychopharmacol. 2021 Aug; 35(8):971-982.

View in: PubMed
Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response. J Psychiatr Res. 2018 06; 101:72-79.

View in: PubMed
Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study. J Clin Psychiatry. 2016 Dec; 77(12):1695-1701.

View in: PubMed
Serotonergic agents act on 5-HT3 receptors in the brain to block seizure-induced respiratory arrest in the DBA/1 mouse model of SUDEP. Epilepsy Behav. 2016 11; 64(Pt A):166-170.

View in: PubMed
Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain. J Cereb Blood Flow Metab. 2017 Feb; 37(2):425-434.

View in: PubMed
Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting. J Nerv Ment Dis. 2016 Jul; 204(7):519-23.

View in: PubMed
Serotonin and impulsive aggression. CNS Spectr. 2015 Jun; 20(3):295-302.

View in: PubMed
Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice. Behav Brain Res. 2014 Nov 01; 274:264-9.

View in: PubMed
Posterior spinal artery aneurysm rupture after 'Ecstasy' abuse. BMJ Case Rep. 2014 Jul 03; 2014.

View in: PubMed
Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors. J Nucl Med. 2014 Apr; 55(4):640-6.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Psychopharmacology (Berl)
J Clin Psychiatry
Addiction
Pharmacol Ther
Pharmacol Biochem Behav
Behav Pharmacol
Ann Intern Med
Am J Physiol Regul Integr Comp Physiol
Am J Med
AAPS J